On April 20, 2023, Illumina Inc announced that it has filed a definitive proxy statement with Securities and Exchange Commission, requesting the shareholders of the Company to vote for its board nominees John Thompson, Francis DeSouza, Frances Arnold, Caroline Dorsa, Robert Epstein, Scott Gottlieb, Gary Guthart, Philip Schiller and Susan Siegel, and a proposal to approve compensation provided to Company named executive officers, recommended the shareholders to withhold vote for the Icahn Groupâs nominees Vincent Intrieri, Jesse Lynn and Andrew Teno, at the annual meeting of shareholders scheduled to be held on May 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115 USD | -0.49% | +3.97% | -17.40% |
05-15 | Daiwa Securities Adjusts Price Target on Illumina to $120 From $133 | MT |
05-14 | Transcript : Illumina, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 08:30 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.40% | 18.32B | |
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+2.62% | 64.85B | |
+18.24% | 54.33B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Illumina Inc Solicits Proxies from Shareholders